放疗在去势抵抗性转移性前列腺癌治疗中的作用。
The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer.
机构信息
Department of Radiation Oncology, British Columbia Cancer Agency, Cancer Centre for the Southern Interior, Kelowna, BC, Canada.
Department of Radiation Oncology, Cancer Centre for the Southern Interior, 399 Royal Avenue, Kelowna, BC, Canada V1Y 5L3.
出版信息
Ther Adv Urol. 2015 Jun;7(3):135-45. doi: 10.1177/1756287215576647.
Abstract
In the setting of castrate-resistant prostate cancer, patients present with a variety of symptoms, including bone metastases, spinal cord compression and advanced pelvic disease. Fortunately, a variety of radiotherapeutic options exist for palliation. This article focuses on these options, including both external beam radiotherapy and radiopharmaceuticals.
摘要
在去势抵抗性前列腺癌的背景下，患者表现出多种症状，包括骨转移、脊髓压迫和晚期盆腔疾病。幸运的是，有多种放射治疗选择可用于缓解症状。本文重点介绍这些选择，包括外照射放疗和放射性药物。
相似文献
1
The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer.
Ther Adv Urol. 2015 Jun;7(3):135-45. doi: 10.1177/1756287215576647.
2
Integrating bone targeting radiopharmaceuticals into the management of patients with castrate-resistant prostate cancer with symptomatic bone metastases.
Curr Treat Options Oncol. 2015 Mar;16(3):325. doi: 10.1007/s11864-014-0325-1.
3
Palliative radiotherapy for prostate cancer.
Oncology (Williston Park). 2014 Apr;28(4):306-12.
4
Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Cancer Prev Control. 1998 Apr;2(2):79-87.
5
Radiation for Treatment of Painful Bone Metastases.
Hematol Oncol Clin North Am. 2018 Jun;32(3):459-468. doi: 10.1016/j.hoc.2018.01.008. Epub 2018 Mar 17.
6
Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases.
Ther Adv Urol. 2016 Jun;8(3):175-80. doi: 10.1177/1756287216629870. Epub 2016 Feb 25.
7
Ra α-Therapy in Patients with Bone Metastases from Castration-resistant Prostate Cancer.
J Med Imaging Radiat Sci. 2015 Jun;46(2):156-161. doi: 10.1016/j.jmir.2015.01.003. Epub 2015 Mar 11.
8
Isotope Therapy for Castrate-Resistant Prostate Cancer: Unique Sequencing and Combinations.
Cancer J. 2016 Sep/Oct;22(5):342-346. doi: 10.1097/PPO.0000000000000218.
9
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
10
Radiation-based approaches for therapy and palliation of advanced prostate cancer.
Curr Opin Urol. 2012 May;22(3):183-9. doi: 10.1097/MOU.0b013e32835259d2.
引用本文的文献
1
Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Ra: PARABO, a Prospective, Noninterventional Study.
J Nucl Med. 2023 Sep;64(9):1392-1398. doi: 10.2967/jnumed.123.265557. Epub 2023 Jun 29.
2
Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?
J Clin Med. 2021 Oct 31;10(21):5124. doi: 10.3390/jcm10215124.
3
Development of I-ixolaris as a theranostic agent: metastatic melanoma preclinical studies.
Clin Exp Metastasis. 2020 Aug;37(4):489-497. doi: 10.1007/s10585-020-10036-0. Epub 2020 May 11.
4
Non-oncologist Physician Knowledge of Radiation Therapy at an Urban Community Hospital.
J Cancer Educ. 2021 Feb;36(1):199-206. doi: 10.1007/s13187-019-01618-y.
5
Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer.
Asian J Androl. 2017 Dec 29;21(1):12-8. doi: 10.4103/aja.aja_59_17.
6
miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer.
Oncol Lett. 2017 Dec;14(6):6895-6900. doi: 10.3892/ol.2017.7041. Epub 2017 Sep 25.
7
Radium-223 dichloride in clinical practice: a review.
Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1896-909. doi: 10.1007/s00259-016-3386-5. Epub 2016 Apr 28.
8
Assessment of Radiation Induced Therapeutic Effect and Cytotoxicity in Cancer Patients Based on Transcriptomic Profiling.
Int J Mol Sci. 2016 Feb 19;17(2):250. doi: 10.3390/ijms17020250.
9
MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma.
Onco Targets Ther. 2015 Dec 17;8:3827-35. doi: 10.2147/OTT.S92314. eCollection 2015.
本文引用的文献
1
Alpha emitter radium-223 and survival in metastatic prostate cancer.
N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755.
2
Intermittent versus continuous androgen deprivation in prostate cancer.
N Engl J Med. 2013 Apr 4;368(14):1314-25. doi: 10.1056/NEJMoa1212299.
3
Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases.
Clin Genitourin Cancer. 2013 Mar;11(1):20-6. doi: 10.1016/j.clgc.2012.07.002. Epub 2012 Sep 26.
4
A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer.
Eur Urol. 2013 Feb;63(2):189-97. doi: 10.1016/j.eururo.2012.09.008. Epub 2012 Sep 13.
5
Pain relief by Cyberknife radiosurgery for spinal metastasis.
Tumori. 2012 Mar-Apr;98(2):238-42. doi: 10.1177/030089161209800210.
6
The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy.
Clin Oncol (R Coll Radiol). 2012 Nov;24(9):629-39. doi: 10.1016/j.clon.2012.04.006. Epub 2012 May 24.
7
Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study.
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e627-31. doi: 10.1016/j.ijrobp.2011.10.081. Epub 2012 May 12.
8
Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases.
Cancer. 2012 Oct 15;118(20):5069-77. doi: 10.1002/cncr.27530. Epub 2012 Apr 17.
9
A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression.
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):312-7. doi: 10.1016/j.ijrobp.2012.01.014. Epub 2012 Mar 13.
10
Split-course, high-dose palliative pelvic radiotherapy for locally progressive hormone-refractory prostate cancer.
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e205-11. doi: 10.1016/j.ijrobp.2011.12.028. Epub 2012 Feb 16.
Zotero 插件